Metabolomics

Dataset Information

0

Targeting Myelin Sphinomyelin concentrations of Kallikrein 6 Signals through PAR1 and PAR2 to Enchance Recovery of Function after SCI

ABSTRACT:

ORGANISM(S): Mus Musculus

TISSUE(S): Spinal Cord

DISEASE(S): Spinal Cord Injury

PROVIDER: ST000853 | MetabolomicsWorkbench |

REPOSITORIES: MetabolomicsWorkbench

Json Xml

Dataset's files

Source:
Action DRS
mwtab Other
Items per page:
1 - 1 of 1

Similar Datasets

Metabolomics Targeting Myelin Sphingolipids of Kallikrein 6 Signals through PAR1 and PAR2 to Enchance Recovery of Function after SCI
| ST000851 | MetabolomicsWorkbench
Metabolomics Targeting Myelin Cholesterol of Kallikrein 6 Signals through PAR1 and PAR2 to Enchance Recovery of Function after SCI
| ST000850 | MetabolomicsWorkbench
Metabolomics Targeting Myelin Galactosyl Sphingolipids of Kallikrein 6 Signals through PAR1 and PAR2 to Enchance Recovery of Function after SCI
| ST000852 | MetabolomicsWorkbench
Metabolomics Targeting Myelin FFA Compostion of Kallikrein 6 Signals through PAR1 and PAR2 to Enchance Recovery of Function after SCI
| ST000849 | MetabolomicsWorkbench
Metabolomics Targeted Galactosyl Sphingolipids Concentrations of Myelin to Enhance Recovery of Function after SCI
| ST000797 | MetabolomicsWorkbench
Unknown Targeting microvasculature for neuroprotection after SCI.
| S-EPMC3101824 | biostudies-literature
Metabolomics Targeted TCA Panel of Myelin to Enhance Recovery of Function after SCI
| ST000799 | MetabolomicsWorkbench
Metabolomics Targeted Sphinomyelin Panel of Myelin to Enhance Recovery of Function after SCI
| ST000798 | MetabolomicsWorkbench
Metabolomics Targeted Sphingolipids Panel of Myelin to Enhance Recovery of Function after SCI
| ST000796 | MetabolomicsWorkbench
Metabolomics Targeted Cholesterol Profiling of Myelin to Enhance Recovery of Function after SCI
| ST000795 | MetabolomicsWorkbench